Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank36
3Y CAGR-27.7%
5Y CAGR-35.9%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-27.7%/yr
vs -32.1%/yr prior
5Y CAGR
-35.9%/yr
Recent acceleration
Acceleration
+4.4pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
5 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.37 | -50.4% |
| 2024 | 6.80 | -16.1% |
| 2023 | 8.10 | -9.2% |
| 2022 | 8.92 | -45.0% |
| 2021 | 16.22 | -47.8% |
| 2020 | 31.08 | +33.4% |
| 2019 | 23.30 | -44.6% |
| 2018 | 42.03 | -94.4% |
| 2017 | 753.82 | -96.4% |
| 2016 | 20927.48 | - |